These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21125811)

  • 1. Antioxidative effects of thiazide diuretics in refractory hypertensive patients. A randomized crossover trial of chlortalidone and trichlormethiazide.
    Sato K; Dohi Y; Kojima M; Takase H; Suzuki S; Ito S
    Arzneimittelforschung; 2010; 60(10):612-6. PubMed ID: 21125811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.
    Ishimitsu T; Numabe A; Masuda T; Akabane T; Okamura A; Minami J; Matsuoka H
    Hypertens Res; 2009 Nov; 32(11):962-8. PubMed ID: 19696778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.
    Musini VM; Nazer M; Bassett K; Wright JM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003824. PubMed ID: 24869750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy of calcium channel blocker and angiotensin II receptor blocker reduces augmentation index in hypertensive patients.
    Doi M; Miyoshi T; Hirohata S; Kamikawa S; Usui S; Kaji Y; Sakane K; Ogawa H; Ninomiya Y; Kusachi S
    Am J Med Sci; 2010 May; 339(5):433-9. PubMed ID: 20234301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker.
    Yutaka M; Mifune M; Kubota E; Itoh H; Saito I
    Clin Exp Hypertens; 2009 Nov; 31(8):648-56. PubMed ID: 20001457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress.
    Yamanari H; Nakamura K; Miura D; Yamanari S; Ohe T
    Clin Exp Hypertens; 2009 Oct; 31(7):585-94. PubMed ID: 19886856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.
    Suzuki R; Fukuda N; Katakawa M; Tsunemi A; Tahira Y; Matsumoto T; Ueno T; Soma M
    Am J Hypertens; 2014 May; 27(5):695-701. PubMed ID: 24200748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
    Chen JM; Heran BS; Perez MI; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.
    Stergiou GS; Malakos JS; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):412-6. PubMed ID: 9125681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial.
    Takihata M; Nakamura A; Kondo Y; Kawasaki S; Kimura M; Terauchi Y
    PLoS One; 2015; 10(5):e0125519. PubMed ID: 25938807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the antihypertensive effect of a thiazide diuretic in angiotensin II-induced hypertension.
    Ballew JR; Fink GD
    J Hypertens; 2001 Sep; 19(9):1601-6. PubMed ID: 11564980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular effects of M17055, furosemide and thiazide on cardiac hypertrophy of spontaneously hypertensive rats.
    Kim S; Hamaguchi A; Shinkawa T; Kato Y; Tsuchiya N; Miura K; Ohta K; Iwao H
    J Pharmacol Exp Ther; 1996 Nov; 279(2):983-90. PubMed ID: 8930208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term evaluation of combined antihypertensive therapy with lisinopril and a thiazide diuretic in patients with essential hypertension.
    Ishimitsu T; Yagi S; Ebihara A; Doi Y; Domae A; Shibata A; Kimura M; Sugishita Y; Sagara E; Sakamaki T; Murata K
    Jpn Heart J; 1997 Nov; 38(6):831-40. PubMed ID: 9486936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the angiotensin II receptor antagonist losartan on diuretic-induced metabolic effects in elderly hypertensive patients: comparison with a calcium channel blocker.
    Ohnishi K; Kohno M; Yukiiri K; Masugata H; Wada Y; Takagi Y; Ohmori K
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):417-22. PubMed ID: 11680666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring　- The NOCTURNE Study.
    Kario K; Tomitani N; Kanegae H; Ishii H; Uchiyama K; Yamagiwa K; Shiraiwa T; Katsuya T; Yoshida T; Kanda K; Hasegawa S; Hoshide S
    Circ J; 2017 Jun; 81(7):948-957. PubMed ID: 28321001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators.
    Uzu T; Harada T; Namba T; Yamamoto R; Takahara K; Yamauchi A; Kimura G
    J Hypertens; 2005 Apr; 23(4):861-5. PubMed ID: 15775792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2981-97. PubMed ID: 12479763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.